Detrusitol SR 4mg Capsule
Manufacturer
Pfizer Ltd
Salt Composition
Tolterodine (4mg)
Key Information
Short Description
Detrusitol SR 4mg Capsule is used in the treatment of overactive bladder. It relieves urinary symptoms like frequent urination, urgent need to urinate, and inability to control urination.
Dosage Form
Capsule SR
Introduction
Detrusitol SR 4mg Capsule is advised to take it in a dose and duration as per prescription. It can be taken with or without food but take it at the same time regularly. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Detrusitol SR 4mg Capsule may be taken with or without food but it is better to take it at a fixed time.
How it works
Detrusitol SR 4mg Capsule is an antimuscarinic. It works by relaxing muscles of the urinary bladder and prevents frequent, urgent or uncontrolled urination.
Quick Tips
Detrusitol SR 4mg Capsule treats symptoms of an overactive bladder by lowering the urge to urinate and controlling urination. It can take up to 4 weeks before you see any improvement in your symptoms. Keep taking it as prescribed. Avoid caffeine, alcohol, and carbonated drinks as they can worsen your symptoms. It may cause dizziness and blurring of vision. Don't drive or do anything that requires mental focus until you know how it affects you. Dry mouth, dry eyes, and constipation may occur as a side effect. Maintain good oral hygiene, drink water frequently, chew sugarless gum, and wear contact lenses with caution.
Frequently asked questions
What is the typical timeframe for experiencing improvements in symptoms after starting Detrusitol SR 4mg Capsule?
You may start noticing symptom improvements within 1 week of beginning treatment. Maximum benefits are typically seen after 5-8 weeks of therapy, and your doctor may recommend long-term use of up to 24 months to maintain these gains.
What class of medication is Detrusitol SR 4mg Capsule, and is it a diuretic?
Detrusitol SR 4mg Capsule belongs to the muscarinic receptor blocker category. It's specifically classified as a urinary antispasmodic rather than a diuretic. This means it helps relax the bladder wall, improving urine control and increasing storage capacity.
Can I stop taking Detrusitol SR 4mg Capsule even if my symptoms improve?
While Detrusitol SR 4mg Capsule can help manage overactive bladder symptoms, it's essential to continue therapy as directed by your doctor. Stopping the medication may cause symptoms to return, and regular check-ups will be necessary to reassess treatment duration.
Can I crush or chew the tablets of Detrusitol SR 4mg Capsule?
No, it's not recommended to crush or chew the tablets. Take them whole with a glass of water, either with or without food, as directed by your doctor.
Is Detrusitol SR 4mg Capsule suitable for use in children?
Research has shown that Detrusitol SR 4mg Capsule does not effectively alleviate overactive bladder symptoms in children. As a result, its use in this age group is not advised.
Who should avoid taking Detrusitol SR 4mg Capsule?
This medication is not recommended for individuals with urinary retention, delayed stomach emptying or intestinal blockage, narrow-angle glaucoma, or myasthenia gravis. Those hypersensitive to Tolterodine should also avoid using it.
Will I experience any adverse effects if I discontinue Detrusitol SR 4mg Capsule due to constipation?
Discontinuing Detrusitol SR 4mg Capsule will not cause harmful effects, but symptoms of overactive bladder may return. Discuss your concerns with your doctor and stop the medication as advised.
Can Detrusitol SR 4mg Capsule cause dementia?
While a direct link between Detrusitol SR 4mg Capsule and dementia is unclear, reports suggest that individuals with dementia may experience worsened symptoms when given this medication. Further research is needed to confirm this association.
